Search CORE

276 research outputs found

Ecological changes with minor effect initiate evolution to delayed regime shifts

Author: Chaparro-Pedraza P.C.
de Roos A.M.
Publication venue: 'Springer Science and Business Media LLC'
Publication date: 01/03/2020
Field of study

International Migration, Integration and Social Cohesion online publications

UvA-DARE

Individual energy dynamics reveal nonlinear interaction of stressors threatening migratory fish populations

Author: Chaparro-Pedraza P.C.
de Roos A.M.
Publication venue: 'Wiley'
Publication date: 01/03/2021
Field of study

International Migration, Integration and Social Cohesion online publications

Density‐dependent effects of mortality on the optimal body size to shift habitat: Why smaller is better despite increased mortality risk

Author: Chaparro-Pedraza P.C.
de Roos A.M.
Publication venue: 'Wiley'
Publication date: 01/05/2020
Field of study

International Migration, Integration and Social Cohesion online publications

Environmental change effects on life-history traits and population dynamics of anadromous fishes

Author: Chaparro-Pedraza P.C.
de Roos A.M.
Publication venue: 'Wiley'
Publication date: 01/08/2019
Field of study

International Migration, Integration and Social Cohesion online publications

Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

Author: Abad M.D.C.B.
Abanedes C.I.S.
Aizpuru E.M.F.
Alcalá J.N.
Alegría J.G.
Amezua C.H.
Amodeo Oblitas C.M.
Andreu M.D.M.G.
Antúnez M.G.
Arenzana C.B.
Aseguinolaza M.G.
Ayala-Gutiérrez M.M.
Ayuso B.
Bailón M.M.
Balaz D.
Bandera V.A.
Beamonte E.D.C.
Beato R.A.
Benbunan C.C.
Bengoa G.D.
Bermejo C.L.
Bermúdez M.
Blanco A.L.
Bueso T.S.
Buonaiuto V.A.
Caleya J.F.L.
Calvo C.M.
Campo B.M.
Candalija A.C.
Capitán C.F.
Carmona J.M.
Carracedo E.F.
Carrasco A.G.
Carrillo R.
Carvajal M.C.C.
Casado L.P.
Casanova P.C.
Casas L.A.
Casas-Rojo J.-M.
Castro S.M.
Cañas C.A.
Cebrián M.B.
Chamorro L.M.T.
Christophel A.T.F.-T.
Clotet N.C.
Corbella X.
Corral J.B.
Corral-Gudino L.
Cruz A.F.
Cuchillo J.B.
Cánovas J.S.
De Blas P.A.
De La Calle G.M.
De La Chica M.N.
De Luque C.M.C.
De Oña Á.A.
De Pedro I.P.
De Santos S.
De Windt F.
Del Pino J.L.
Delgado C.M.
Do Rego A.T.
Elías A.E.C.
Escalante M.D.M.
Escudero S.C.
Estrada A.D.B.
Etayo M.Z.
Fernandez-Bravo I.G.
Fernandez-Castelao S.
Fernández A.M.
Fernández F.A.
Fernández M.S.
Fernández P.C.
Fernández-Garcés M.
Fernández-Llamazares G.S.
Fonseca J.B.
Fontan P.M.P.
Fontán P.M.P.
Frías M.C.
Galeano Valle F.
Galvañ V.G.
Garcia A.
Garcia M.V.V.
García A.T.
García C.A.
García García G.M.
García J.G.
García S.L.
Gil C.R.H.
Godoy R.M.
Gonzalo J.L.
Gonzalo L.A.
Grela A.G.
Guerrero M.B.
Guillan E.M.P.
Gurjian A.A.
Gutiérrez J.C.M.
Gómez A.E.
Gómez C.R.
Gómez J.A.
Hernández A.L.
Hernández C.D.
Hernández M.J.J.
Homs N.
Hontañón V.
Huelgas R.G.
Huerta L.J.
Hurtado Oliver J.A.
Ibáñez L.J.
Iglesias M.F.G.
Iscar C.O.
Jansen-Chaparro S.
Jenaro M.M.F.-M.
Jimeno V.M.
Jiménez P.D.
Jiménez-García N.
Klepzig J.L.G.
Lahoz C.
Laorden C.J.
Ledesma S.M.
Leoni M.E.G.
Lezaun C.G.
Llorente B.P.
Lora-Tamayo J.
Lorenzo-Hernández E.
López C.M.O.
López I.B.
López M.M.M.
López M.N.
López R.B.
López-Carmona M.D.
Macías M.T.
Manau J.V.
Manglano J.D.
Manuel E.C.
Martínez D.L.
Martínez J.M.H.
Martínez L.F.C.
Martínez M.L.T.
Martínez R.F.-M.
Mayoral M.V.
Mendo C.L.
Mera I.F.
Molina S.C.
Montero A.
Montes J.T.
Mora-Luján J.M.
Morejón J.B.
Moreno A.D.C.
Moreno M.C.
Mozo A.N.
Murgui R.M.
Muriel C.C.
Muñoz B.G.
Muñoz E.C.
Muñoz J.A.
Míguez A.M.
Narciso C.G.S.
Nohales C.M.
Nuñez M.P.
Núñez-Cortés J.M.
Ocaña P.G.
Olleros C.L.
Ortega L.O.
Palacios L.C.
Pampyn M.P.
Pedroche C.D.
Peláez E.P.
Peralta E.E.D.
Perpiña B.O.
Pineda-Cantero A.
Prieto J.M.M.
Prieto M.M.
Purificación A.S.
Pérez S.C.
Pérez V.E.
Pérez-Belmonte L.M.
Quintana F.B.
Quirantes P.L.
Ramos J.C.
Reyne A.G.
Rhyman N.
Ricci M.
Rivera N.A.
Robles E.M.
Rodriguez V.N.
Rodríguez-Mancheño A.L.
Romero F.N.
Romero M.A.F.
Royo Trallero L.E.
Rubio-Rivas M.
Ruiz D.P.
Ruiz S.P.
Ruperto L.R.
Saavedra M.O.F.
Saldaña A.M.
Samaniego N.T.
Sampalo A.L.
Sanz M.T.M.
Sanz M.T.P.
Sevilla J.J.M.
Sierra J.O.
Simon R.D.
Simón M.A.Q.
Suárez A.M.Á.
Sánchez S.P.
Tabares Y.U.
Tejido S.C.
Torre R.S.
Troncoso J.Á.
Veganzones L.I.
Vergés C.D.
Vidal A.D.
Vieitez A.C.
Vilan L.D.
Villarreal G.
Virto A.P.
Wikman-Jorgensen P.E.
Yeguas I.A.
Zapico A.M.
Publication venue: 'MDPI AG'
Publication date: 01/01/2021
Field of study

Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations. Material and methods: A retrospective, descriptive, and observational study was conducted on adults hospitalised due to COVID-19 in Spain who were included in the SEMI-COVID- 19 Registry from March to November 2020. Results: CTs were used in 6053 (36.21%) of the included patients. The patients were older (mean (SD)) (69.6 (14.6) vs. 66.0 (16.8) years; p < 0.001), with hypertension (57.0% vs. 47.7%; p < 0.001), obesity (26.4% vs. 19.3%; p < 0.0001), and multimorbidity prevalence (20.6% vs. 16.1%; p < 0.001). These patients had higher values (mean (95% CI)) of C-reactive protein (CRP) (86 (32.7-160) vs. 49.3 (16-109) mg/dL; p < 0.001), ferritin (791 (393-1534) vs. 470 (236- 996) µg/dL; p < 0.001), D dimer (750 (430-1400) vs. 617 (345-1180) µg/dL; p < 0.001), and lower Sp02/Fi02 (266 (91.1) vs. 301 (101); p < 0.001). Since June 2020, there was an increment in the use of CTs (March vs. September; p < 0.001). Overall, 20% did not receive steroids, and 40% received less than 200 mg accumulated prednisone equivalent dose (APED). Severe patients are treated with higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%. Conclusions: Patients with greater comorbidity, severity, and inflammatory markers were those treated with CTs. In severe patients, there is a trend towards the use of higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%